Back to Search
Start Over
Focus on heart failure and cardiomyopathies: new ESC Guidelines and key meta-analyses.
- Source :
- European Heart Journal; 10/1/2023, Vol. 44 Issue 37, p3487-3491, 5p
- Publication Year :
- 2023
-
Abstract
- Eur Heart J 2023; 44: 3658 - 68. https://doi.org/10.1093/eurheartj/ehad346 Google Scholar OpenURL Placeholder Text WorldCat 13 Angermann CE, Ertl G. Remote heart failure management guided by pulmonary artery pressure home monitoring: rewriting the future? This commercially available technology uses a wireless implantable sensor powered externally by radiofrequency energy placed in a branch of the left pulmonary artery to transmit daily snapshot estimates of PAP to health-care providers, thus facilitating close remote patient management without the need for in-person visits, and timely dynamic adjustments of HF treatments as required. The SGLT2 inhibitors have established themselves as robust, disease-modifying therapies and as recent trial results are incorporated into clinical guidelines, will likely become foundational in the therapy of HFpEF. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 0195668X
- Volume :
- 44
- Issue :
- 37
- Database :
- Complementary Index
- Journal :
- European Heart Journal
- Publication Type :
- Academic Journal
- Accession number :
- 172443390
- Full Text :
- https://doi.org/10.1093/eurheartj/ehad647